Notoginsenoside R1 attenuates ischemic stroke via CKLF1-dependent suppression of neuronal metabolic reprogramming
NGR1 alleviates ischemic neuronal injury, at least in part, by interfering with CKLF1/CCR5-associated signaling, thereby attenuating pathological metabolic reprogramming, neuroinflammation, and apoptosis.